Endovascular techniques are still expanding in their capability by introducing novel technologies. Nevertheless, anterior communicating artery (ACoA) remains the region with high propensity for aneurysm (AN) re-growth after endovascular intervention. The purpose of this study is to highlight the ongoing importance for microsurgical treatment. The authors conducted a single-institution retrospective study of ACoA AN treatment between January 2000 and December 2016 maintaining "coil mainly" policy. The results are supplied with a systematic review of the literature. A total of n = 398 ACoA ANs were treated in n = 398 consecutive patients (207 females, 191 males). Microsurgical treatment was performed for 79 AN patients (54 ruptured, 25 unruptured), and 319 AN patients (250 ruptured, 69 unruptured) underwent coiling procedure. Treatment-related morbidity and mortality (MM) for unruptured ANs was 0% in the microsurgical and 1.5% in the endovascular group (p = 1.000). The percentage of patients with none or minor permanent deficits after subarachnoid hemorrhage was 74% in the microsurgical and 70% in the endovascular group (p = 0.693). The re-treatment rate was 3.8% in microsurgical group and 9.2% in endovascular group (p = 0.883). A literature review identified 39 studies concerning ACoA AN treatment. Clinical results of both modalities were comparable, with microsurgery being superior regarding radiological outcomes. This study demonstrates that both treatment techniques bring comparable clinical benefit to the patient. Microsurgery seemed superior regarding radiological outcomes. The decision about the treatment strategy should be made by a multi-disciplinary team consisting of specialists from both teams, bearing in mind the higher occlusion rate and longevity of the surgical treatment.

• MeSH
• arteria cerebri anterior chirurgie   MeSH
• cévní protézy * MeSH
• dospělí MeSH
• endovaskulární výkony metody   MeSH
• implantace prsní náhrady metody   MeSH
• intrakraniální aneurysma chirurgie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• neurochirurgické výkony metody   MeSH
• reoperace statistika a číselné údaje   MeSH
• revaskularizace mozku MeSH
• senioři MeSH
• výsledek terapie MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• metaanalýza MeSH
• přehledy MeSH

BACKGROUND: The proportion of women among neurosurgeons appears to be growing worldwide with time. Official data concerning the current situation across Europe have not yet been published. Thus, there are still concerns about gender inequality. The European Women in Neurosurgery Project 2016 was designed to recognize the current situation across Europe. METHODS: The office holders of the national neurosurgical societies of 39 countries forming the European Association of Neurosurgical Societies were contacted to provide data stating the proportion of women in neurosurgery. Obtained data were supplied with the results of an online survey. RESULTS: The response rate of national office holders was 90%. The number of reported neurosurgeons was 12,985, and overall proportion of women represented was 12%. Two hundred thirty-seven responses to online questionnaire were taken into account. The overall proportion of female respondents was 30%. There was no intergender variability in responses regarding amount of working time per week, exposure to surgeries, or administrative work. Male respondents reported dedicating significantly more time to scientific work and feeling more confident dictating own career direction. Female respondents reported being less often married, having fewer children, a stronger perception of gender significance level, and a higher appreciation of personal qualities. CONCLUSIONS: Neurosurgery is a challenging field of medicine. The results of our survey did not imply an overall feeling of gender inequality among European respondents, although women believe that the gender issue to be more important than men do and that they have to sacrifice more of their personal lives.

• MeSH
• dospělí MeSH
• lékařky statistika a číselné údaje   MeSH
• lidé středního věku MeSH
• lidé MeSH
• manželský stav statistika a číselné údaje   MeSH
• neurochirurgie pracovní síly   MeSH
• neurochirurgové statistika a číselné údaje   MeSH
• postoj zdravotnického personálu * MeSH
• rozložení podle pohlaví MeSH
• sexismus statistika a číselné údaje   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Evropa epidemiologie   MeSH

BACKGROUND: The results of microsurgical treatment for middle cerebral artery (MCA) aneurysms (ANs) have been highly satisfying for decades, notoriously posing a challenge for interventional neuroradiologists. Following the International Subarachnoid Aneurysm Trial (ISAT) study results, most centres across Europe and the USA switched to a "coil first" policy. The purpose of this study is to evaluate and critically review the substantiation of this change. METHODS: The authors conducted a single-institution retrospective study of MCA AN treatment between January 2000 and December 2013 maintaining a "clip first" policy. The results are supplied with a literature review. RESULTS: A total of 315 MCA ANs were treated in 288 consecutive patients (209 females, 79 males). Microsurgical treatment was performed for 238 AN patients (116 ruptured, 122 unruptured) and 77 AN patients (46 ruptured, 31 unruptured) who underwent a coiling procedure. Treatment-related morbidity and mortality (MM) for unruptured ANs was 2.8 % in the microsurgical group and 10.3 % in the endovascular group. The percentage of patients with no/minor permanent neurological deficits after SAH in a good initial clinical state (HH 1-2) was 93 % in the microsurgical and 76 % in the endovascular group. A literature review identified 21 studies concerning MCA AN treatment with a specified decision-making algorithm. Microsurgery seemed superior to endovascular management regarding both clinical and radiological outcomes, although several aspects of the analysed reports might appear questionable. CONCLUSION: Although this study has its inherent limitations, the effect brought about by microsurgical clipping of MCA ANs remains superior to that of endovascular embolisation and it should be sustained as the first treatment choice. The decision about the treatment strategy should be made by a multi-disciplinary team consisting of specialists from both teams, bearing in mind the higher occlusion rate and longevity of the surgical treatment.

• MeSH
• chirurgické nástroje škodlivé účinky   MeSH
• dospělí MeSH
• intrakraniální aneurysma chirurgie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• mikrochirurgie škodlivé účinky   metody   MeSH
• retrospektivní studie MeSH
• senioři MeSH
• směrnice pro lékařskou praxi jako téma MeSH
• terapeutická embolizace škodlivé účinky   metody   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• hodnotící studie MeSH
• přehledy MeSH

Úvod: Kompletní resekce je obecně uznávaný standard léčby GII ependymomů IV. komory u dospělých, zatímco role adjuvantní radioterapie zůstává nejistá. Účelem předkládané studie je zhodnotit lokální kontrolu onemocnění a klinický stav pacientů s tímto onemocněním po chirurgické terapii. Materiál a metody: Retrospektivně jsme zhodnotili 15 pacientů (sedm mužů a osm žen) s histologicky verifikovaným GII ependymomem IV. komory v časovém období leden 2001–prosinec 2011. Výsledky: Kompletní resekce tumoru byla dosažena u 12 pacientů, u žádného z nich nebyla indikována adjuvantní radioterapie. Medián dalšího sledování byl 51 měsíců (min.–max.; 11–123 měsíců). Ke grafické recidivě došlo u jednoho pacienta, ten byl reoperován s časovým odstupem 51 měsíců od prvního zákroku. Nový neurologický deficit po operaci byl zaznamenán ve dvou případech. U dvou ze tří pacientů po subtotální resekci došlo ke grafické progresi rezidua po 11 a 16 měsících od první operace, jeden z nich byl reoperován s odstupem 27 měsíců. Adjuvantní radioterapie byla indikována u obou pacientů po reoperaci. Závěr: Dle našich dat je kompletní resekce efektivní a bezpečná léčba GII ependymomů IV. komory u dospělých. Následná radioterapie by měla být rezervována pro případy subtotální resekce s následnou progresí rezidua tumoru a reoperace.

Introduction: Surgical resection is a generally accepted standard treatment modality in GII posterior fossa ependymomas in adults, while the role of adjuvant radiotherapy remains unclear. The purpose of this study was to evaluate local control of tumor growth and clinical outcome of patients after surgical treatment of GII fourth ventricle ependymomas. Material and methods: We conducted a retrospective study of 15 adult patients (seven males and eight females) with histologically confirmed GII fourth ventricular ependymoma between January 2001 and December 2011. Results: Gross total resection was achieved in 12 patients, none of them received adjuvant treatment after the initial surgery. Median follow-up after GTR was 51 months (min. – max.; 11–123 months). One patient showed radiographic signs of tumor recurrence and was re-operated 51 months after the initial surgery. Remaining patients were without any signs of tumor recurrence. After the surgery, a new neurological deficit occurred in two patients. Two of the three patients after subtotal tumor resection showed residual mass progression after 11 and 16 months postoperatively, one of them was re-operated 27 months after the initial surgery. Adjuvant radiotherapy was indicated in both re-operated patients. Conclusion: According to our data, gross total resection is effective and safe treatment of GII fourth ventricle ependymomas. Adjuvant radiotherapy should be reserved for the cases where complete removal of tumor mass is not possible and residual tumor is growing, or after repeated resection. Key words: ependymoma – adult – fourth ventricle – posterior fossa surgery – survival recurrence – radiotherapy The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study. The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

• MeSH
• adjuvantní radioterapie statistika a číselné údaje   MeSH
• analýza přežití MeSH
• čtvrtá mozková komora * chirurgie   MeSH
• dospělí MeSH
• ependymom * chirurgie   mortalita   radioterapie   MeSH
• infratentoriální nádory * chirurgie   mortalita   radioterapie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• lokální recidiva nádoru chirurgie   mortalita   radioterapie   MeSH
• nádory mozku chirurgie   mortalita   radioterapie   MeSH
• neurochirurgické výkony metody   mortalita   statistika a číselné údaje   MeSH
• peroperační komplikace MeSH
• pooperační komplikace MeSH
• přežití bez známek nemoci MeSH
• reoperace statistika a číselné údaje   MeSH
• retrospektivní studie MeSH
• reziduální nádor chirurgie   radioterapie   MeSH
• senioři MeSH
• stupeň nádoru MeSH
• výsledek terapie MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• práce podpořená grantem MeSH

• Publikační typ
• abstrakt z konference MeSH